You'll Be Stunned by How Many Cancer Immunotherapies Are Being Developed
For years, chemotherapy was the best treatment that the world of medicine had to offer in fighting cancer. That's no longer true. A powerful new class of cancer drugs called immunotherapies has become increasingly effective at treating cancer. These immunotherapies, also known as immuno-oncology (I-O) drugs, harness the body's own immune system to fight cancer. And they're becoming more popular in the research community than you might imagine.
The Cancer Research Institute (CRI) just published the most comprehensive assessment ever of the state of research and development for immunotherapies. This report identified a staggering 2,004 immunotherapies in development or on the market across the world.
For cancer patients, this means there are more experimental I-O drugs than ever before that hold hope for more effective treatment. But there's also a downside to having so many drugs being researched.
Source: Fool.com
Gilead Sciences Inc Stock
We see a rather positive sentiment for Gilead Sciences Inc with 11 Buy predictions and 1 Sell predictions.
With a target price of 86 € there is a positive potential of 45.34% for Gilead Sciences Inc compared to the current price of 59.17 €.
